Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: A case report and review of the literature

Clinical Rheumatology

Volumn 29, Issue 5, 2010, Pages 563-566

  Ishikawa, Yuki ^a   Yukawa, Naoichiro ^a,b   Ohmura, Koichiro ^a,b   Hosono, Yuji ^a   Imura, Yoshitaka ^a,b   Kawabata, Daisuke ^a,b   Nojima, Takaki ^a,b   Fujii, Takao ^a,b   Usui, Takashi ^a,b   Mimori, Tsuneyo ^a,b  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Anti Jo 1 antibody; Anti TNF therapy; Antisynthetase antibodies; Dermatomyositis; Polymyositis; Rheumatoid arthritis

Indexed keywords

ANTINUCLEAR ANTIBODY; BUCILLAMINE; CORTICOSTEROID; CREATINE KINASE; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOSPORIN; ETANERCEPT; JO 1 ANTIBODY; METHYLPREDNISOLONE; PREDNISOLONE; TACROLIMUS;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTHRALGIA; ARTICLE; BONE EROSION; CASE REPORT; CREATINE KINASE BLOOD LEVEL; DISEASE COURSE; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; DRUG WITHDRAWAL; ELECTROMYOGRAM; FEMALE; HAND RADIOGRAPHY; HUMAN; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; JOINT CAVITY; JOINT RADIOGRAPHY; JOINT SWELLING; LOW DRUG DOSE; LYMPHOCYTIC INFILTRATION; MORNING STIFFNESS; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYALGIA; POLYMYOSITIS; PRIORITY JOURNAL; RELAPSE; REMISSION; RHEUMATOID ARTHRITIS; SIDE EFFECT;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, ANTINUCLEAR; ARTHRITIS, RHEUMATOID; DERMATOMYOSITIS; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION; MIDDLE AGED; POLYMYOSITIS; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 77950857508     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1370-1     Document Type: Article

References (15)

1. L Weaver 2004 Efficacy and safety of the anti-TNF biologic agents Mod Rheumatol 14 101 112 10.1007/s10165-004-0275-8 1:CAS:528:DC%2BD2cXlt1Glu74%3D 17143658 (Pubitemid 40796170)
2. S Salomonsson IE Lundberg 2006 Cytokines in idiopathic inflammatory myopathies Autoimmunity 39 3 177 190 10.1080/08916930600622256 1:CAS:528:DC%2BD28XnsFGltb4%3D 16769651 (Pubitemid 43879030)
3. I Labioche E Liozon B Weschler V Loustaud-Ratti P Soria E Vidal 2004 Refractory polymyositis responding to infliximab: extended follow-up [letter] Rheumatology (Oxford) 43 531 532 10.1093/rheumatology/keh079 1:STN:280:DC%2BD2c7jt1WhsA%3D%3D (Pubitemid 38489380)
4. A Selva-O'Callaghan X Martinez-Costa R Solans-Laque M Mauri JA Capdevila M Vilardell-Tarres 2004 Refractory adult dermatomyositis with pneumatosis cystoides intestinalis with infliximab [letter] Rheumatology (Oxford) 43 1196 1197 10.1093/rheumatology/keh285 (Pubitemid 39232831)
5. I Uthman J El-Sayad 2004 Refractory polymyositis responding to infliximab [letter] Rheumatology (Oxford) 43 1198 10.1093/rheumatology/keh268 1:CAS:528:DC%2BD2cXntFagsLc%3D (Pubitemid 39232833)
6. AK Imperato S Smiles SB Abramson 2004 Long-term risks associated with biologic response modifiers used in rheumatic diseases Curr Opin Rheumatol. 16 199 205 10.1097/00002281-200405000-00006 15103245 (Pubitemid 38530486)
7. P Efthimiou 2006 Tumor necrosis factor-alpha in inflammatory myopathies, pathophysiology and therapeutic implications Semin Arthritis Rheum 36 3 168 172 10.1016/j.semarthrit.2006.07.003 1:CAS:528:DC%2BD28XhtFOiu7nL 16970978 (Pubitemid 44691885)
8. GJD Hengstman JL De Bleecker E Feist J Vissing CP Denton MN Manoussakis, et al. 2008 Open-label trial of anti-TNF-α in dermato- and polymyositis treated concomitantly with methotrexate Eur Neurol 59 159 163 10.1159/000114036 1:CAS:528:DC%2BD1cXit1yntb0%3D 18230873 (Pubitemid 351301260)
9. F Iannone C Scioscia PC Falappone M Covelli G Lapadula 2006 Use of etanercept in the treatment of dermatomyositis: a case series J Rheumatol 33 1802 1804 1:CAS:528:DC%2BD28XhtVGisr3P 16960940 (Pubitemid 44373214)
10. M Dastmalchi C Grundtman H Alexanderson CP Mavragani H Einarsdottir S Barbasso Helmers, et al. 2008 A high incidence of disease flares in an open pilot study of infliximab in patients with refractory myopathies Ann Rheum Dis 67 1670 1677 10.1136/ard.2007.077974 1:CAS:528:DC%2BD1MXjs1OitA%3D%3D 18272672
11. AH Harald Z Bernard 2006 Evolution of dermatomyositis during therapy with a tumor necrosis factor α inhibitor Arthritis & Rheum 55 982 984 10.1002/art.22358 (Pubitemid 44917476)
12. J Musial A Undas M Celinska-Lowenhoff 2003 Polymyositis associated with infliximab treatment for rheumatoid arthritis Rheumatology (Oxford) 42 1566 1568 10.1093/rheumatology/keg388 1:STN:280:DC%2BD3srntFyhug%3D%3D (Pubitemid 37508935)
13. Y Urata Y Wakai K Kowatari 2006 Polymyositis associated with infliximab treatment for rheumatoid arthritis Mod Rheumatol 16 410 411 10.1007/s10165-006- 0523-1 17165006 (Pubitemid 44921592)
14. U Kiltz C Fendler J Braun 2008 Neuromuscular involvement in rheumatic patients treated with anti-TNF therapy-three examples J Rheum 35 2074 2075 18843765
15. M Hirakata 2000 Humoral aspects of polymyositis/dermatomyositis Mod rheumatol 10 199 206 10.1007/s101650070002